These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15265902)

  • 1. A synthetic peptide homologous to functional domain of human IL-10 down-regulates expression of MHC class I and Transporter associated with Antigen Processing 1/2 in human melanoma cells.
    Kurte M; López M; Aguirre A; Escobar A; Aguillón JC; Charo J; Larsen CG; Kiessling R; Salazar-Onfray F
    J Immunol; 2004 Aug; 173(3):1731-7. PubMed ID: 15265902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
    Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
    Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
    Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
    Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10.
    Salazar-Onfray F; Charo J; Petersson M; Freland S; Noffz G; Qin Z; Blankenstein T; Ljunggren HG; Kiessling R
    J Immunol; 1997 Oct; 159(7):3195-202. PubMed ID: 9317117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen presentation in syrian hamster cells: substrate selectivity of TAP controlled by polymorphic residues in TAP1 and differential requirements for loading of H2 class I molecules.
    Lobigs M; Müllbacher A; Blanden RV; Hämmerling GJ; Momburg F
    Immunogenetics; 1999 Oct; 49(11-12):931-41. PubMed ID: 10501835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell-mediated immune recognition of human melanoma cells.
    White CA; Thomson SA; Cooper L; van Endert PM; Tampe R; Coupar B; Qiu L; Parsons PG; Moss DJ; Khanna R
    Int J Cancer; 1998 Feb; 75(4):590-5. PubMed ID: 9466661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines.
    Singal DP; Ye M; Ni J; Snider DP
    Immunol Lett; 1996 May; 50(3):149-54. PubMed ID: 8803612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of immunogenicity of a human renal-cell carcinoma cell line by TAP1-gene transfer.
    Kallfelz M; Jung D; Hilmes C; Knuth A; Jaeger E; Huber C; Seliger B
    Int J Cancer; 1999 Mar; 81(1):125-33. PubMed ID: 10077163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma rapidly increases peptide transporter (TAP) subunit expression and peptide transport capacity in endothelial cells.
    Ma W; Lehner PJ; Cresswell P; Pober JS; Johnson DR
    J Biol Chem; 1997 Jun; 272(26):16585-90. PubMed ID: 9195970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma.
    Seliger B; Dunn T; Schwenzer A; Casper J; Huber C; Schmoll HJ
    Scand J Immunol; 1997 Dec; 46(6):625-32. PubMed ID: 9420627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells.
    Khan AN; Gregorie CJ; Tomasi TB
    Cancer Immunol Immunother; 2008 May; 57(5):647-54. PubMed ID: 18046553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface.
    Hallermalm K; Seki K; Wei C; Castelli C; Rivoltini L; Kiessling R; Levitskaya J
    Blood; 2001 Aug; 98(4):1108-15. PubMed ID: 11493458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of defects responsible for impaired Qa-2 class Ib MHC expression on melanoma cells protects mice from tumor growth.
    Chiang EY; Henson M; Stroynowski I
    J Immunol; 2003 May; 170(9):4515-23. PubMed ID: 12707328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of the expression of transports associated with antigen processing in human malignant melanoma increases tumor-specific immunity.
    Tao J; Li Y; Liu YQ; Wang L; Yang J; Dong J; Wu Y; Shen GX; Tu YT
    J Invest Dermatol; 2008 Aug; 128(8):1991-6. PubMed ID: 18385764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to natural killer cell lysis conferred by TAP1/2 genes in human antigen-processing mutant cells.
    Salcedo M; Momburg F; Hämmerling GJ; Ljunggren HG
    J Immunol; 1994 Feb; 152(4):1702-8. PubMed ID: 8120379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells.
    Correa I; Raulet DH
    Immunity; 1995 Jan; 2(1):61-71. PubMed ID: 7541307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of sequences in the human peptide transporter subunit TAP1 required for transporter associated with antigen processing (TAP) function.
    Ritz U; Momburg F; Pircher HP; Strand D; Huber C; Seliger B
    Int Immunol; 2001 Jan; 13(1):31-41. PubMed ID: 11133832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines.
    Frisan T; Donati D; Cervenak L; Wilson J; Masucci MG; Bejarano MT
    Int J Cancer; 1999 Dec; 83(6):772-9. PubMed ID: 10597194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional cysteine-less subunits of the transporter associated with antigen processing (TAP1 and TAP2) by de novo gene assembly.
    Heintke S; Chen M; Ritz U; Lankat-Buttgereit B; Koch J; Abele R; Seliger B; Tampé R
    FEBS Lett; 2003 Jan; 533(1-3):42-6. PubMed ID: 12505156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.